Showing 231-240 of 345 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Sparing ER stressed human beta cells with novel kinase inhibitors of the unfolded protein response (UPR) | The Regents of the University of California, San Francisco | Feroz Papa | Cures | 01-August-2023 to 31-July-2026 | $960.000,00 |
| Validation of a new approach for cardiovascular disease risk stratification and therapeutic targeting in T1D | Joslin Diabetes Center Inc. | Myra Lipes | Improving Lives | 01-September-2023 to 30-June-2027 | $1.341.376,33 |
| Hybrid Closed Loop Therapy for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEX) | Regents of the University of Minnesota | Antoinette Moran | Cures | 01-April-2023 to 31-March-2026 | $1.739.442,00 |
| Repurposing LRRK2 inhibitors for β cell protection in T1D | Regents of the University of Michigan | Scott Soleimanpour | Cures | 01-September-2023 to 31-August-2026 | $750.000,00 |
| Adult T1D Detection at Geisinger | IQVIA, Inc. | Nadejda Leavitt | Cures | 01-July-2023 to 31-May-2026 | $890.727,00 |
| Targeting the Opposing Roles of Prostaglandin E2 Receptors, EP3 and EP4, in the Pathogenesis of Type One Diabetes | Vanderbilt University Medical Center (VUMC) | Maureen Gannon | Cures | 01-October-2023 to 31-March-2026 | $200.000,00 |
| Oxygen Enabled High-capacity Vascularized Devices for ß-cell Replacement Therapy in Humans | Arizona Board of Regents, University of Arizona | Klearchos Papas | Cures | 01-September-2023 to 31-August-2026 | $2.652.490,70 |
| Network for Pancreatic Organ Donors – nPOD | University of Florida | Mark Atkinson | Cures | 01-October-2023 to 30-September-2026 | $8.100.000,00 |
| Autoimmune stem-like T cells in type 1 diabetes | Memorial Sloan-Kettering Cancer Center | Andrea Schietinger | Cures | 01-September-2023 to 31-August-2026 | $750.000,00 |
| Assessment of a Tolerogenic Nanoparticle in a Humanized Mouse Islet Transplantation Model | Northwestern University | Jacqueline Burke | Cures | 01-April-2024 to 31-March-2026 | $499.746,76 |